• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Emphysema Market Trends

    ID: MRFR/Pharma/4354-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Emphysema Market Research Report By Type (Centrilobular, Panlobular), By Diagnosis (Imaging Test (X-Ray, Ct Scan), Lung Function Test), by Treatment (Medication (Antibiotics, Bronchodilators), Therapy, Surgery), by End-User-Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Emphysema Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Emphysema Market

    The emphysema market trends in the sector show a dynamic landscape influenced by different factors, such as advances in medical research, changing treatment approaches as well as rising number of COPD cases globally with emphysema being one of its components. One key trend is the increasing instances of global emphysema incidents triggered mainly by factors like smoking, air pollution and aging populations. Improved understanding about these risk factors and how they relate to emphysema combined with better diagnosis have helped in early detection and intervention. This development highlights the urgency for new innovative ways of tackling the rising burden of emphysema which is a progressive lung illness characterized by destruction of lung tissues. Advances in diagnostic tools like pulmonary function tests; imaging studies including computed tomography (CT) scans and biomarker assessments play an important role in early and accurate diagnosis of emphysema. These techniques help doctors determine extent of damage to lungs, make therapy choices and track progression. Hence this improved diagnostic capacity enables prompt interventions that can initiate appropriate treatment or behavior change for individual patients affected by Emphysema. Pharmaceutical industry focus on respiratory health has contributed to development of various therapeutic options for emphyema and COPD. Bronchodilators, corticosteroids inhalers, combination therapies are some examples given to reduce symptoms thus enhance lungs functioning. Ongoing research is investigating new drug classes such as phosphodiesterase-4 inhibitors or long acting muscarinic antagonists that may add value to treatment alternatives available for patients suffering from Emphysema. This trend emphasizes improving care methods so as to improve outcomes thereby reduce impacts related to respiratory health problems on Emphyesema carriers. Personalized medicine is having an impact on market trends within the context of Emhymea care sectors. Treatment plans are now designed based on individual patient characteristics which include genetic factors among others. The use of precision medicine aims at optimizing therapeutic efficacy while minimizing potential side effects, leading to better results for patients with COPD in the management of Emphysema. Emphhysemacare landscape is shaped by collaboration among healthcare professionals, scientists and pharmaceutical firms. This includes establishment of pulmonary rehabilitation programs, smoking cessation initiatives as well as educating the patient in a coordinated manner. They also facilitate clinical trials and research into emphysema pathophysiology and treatment options. The use of telemedicine and digital health technologies has become an integral part of Emhymea care for post rehabilitation follow up monitoring patients. These technologies allow for remote consultation, offer online support for pulmonary rehabilitation as well as track symptoms and medication adherence. This trend reflects the wider adoption of digital healthcare solutions that provide more convenient ways of managing persistent respiratory diseases. Emerging trends in regenerative medicine and stem cell therapy suggest a potential role for their application in emphysema treatment. Early studies on using stem cells to repair damaged lung tissue or manipulate inflammation show great promise for regenerative medicine approaches to treating emphysema. Though still embryonic, Regenerative Medicine offers another way to treat emphysema which could have curative properties; this is an area that draws attention from many quarters.

    Market Summary

    The Global Emphysema Market is projected to grow from 13.5 USD Billion in 2024 to 22.7 USD Billion by 2035, indicating robust expansion.

    Key Market Trends & Highlights

    Global Emphysema Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 4.83 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 22.7 USD Billion, reflecting a substantial increase from 13.5 USD Billion in 2024.
    • The growth trajectory suggests a rising demand for innovative treatment options in the emphysema sector.
    • Growing adoption of advanced therapies due to increasing prevalence of respiratory diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 13.5 (USD Billion)
    2035 Market Size 22.7 (USD Billion)
    CAGR (2025-2035) 4.83%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc.

    Market Trends

    The increasing prevalence of emphysema, driven by factors such as aging populations and environmental pollutants, underscores the urgent need for enhanced therapeutic strategies and public health initiatives.

    Centers for Disease Control and Prevention (CDC)

    Emphysema Market Market Drivers

    Growing Geriatric Population

    The aging population is a critical driver of the Global Global Emphysema Market Industry. As individuals age, the risk of developing respiratory diseases, including emphysema, increases significantly. The World Health Organization reports that the global population aged 60 years and older is expected to double by 2050, leading to a higher incidence of chronic respiratory conditions. This demographic shift necessitates enhanced healthcare services and treatment options tailored to older adults. Consequently, the Global Global Emphysema Market Industry is likely to see sustained growth, with a compound annual growth rate of 4.83% projected from 2025 to 2035, as the demand for effective management of emphysema rises.

    Advancements in Treatment Options

    Innovations in treatment methodologies are propelling the Global Global Emphysema Market Industry forward. New pharmacological therapies, including bronchodilators and corticosteroids, are being developed to enhance patient outcomes. Additionally, the emergence of biologics and targeted therapies offers promising avenues for managing emphysema. Clinical trials and research initiatives are ongoing, suggesting that these advancements could lead to improved efficacy and safety profiles for patients. As the industry evolves, the market is projected to grow, potentially reaching 22.7 USD Billion by 2035, reflecting the increasing investment in research and development within the Global Global Emphysema Market Industry.

    Increased Awareness and Education

    Rising awareness and education regarding respiratory health are influencing the Global Global Emphysema Market Industry positively. Public health campaigns and initiatives aimed at educating individuals about the risks associated with smoking and air pollution are gaining traction. These efforts are likely to lead to earlier diagnosis and treatment of emphysema, ultimately improving patient outcomes. Furthermore, healthcare providers are increasingly focusing on preventive measures, which may reduce the overall burden of the disease. As awareness continues to grow, the market is expected to expand, aligning with the projected increase in market value to 22.7 USD Billion by 2035.

    Market Trends and Growth Projections

    The Global Global Emphysema Market Industry is characterized by various trends that indicate its growth trajectory. The market is projected to expand significantly, with estimates suggesting a value of 22.7 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 4.83% from 2025 to 2035. Key trends include the increasing adoption of telemedicine for respiratory care, the integration of artificial intelligence in diagnostics, and the rise of personalized medicine approaches. These trends reflect the industry's adaptability and responsiveness to changing healthcare needs, positioning the Global Global Emphysema Market Industry for a robust future.

    Regulatory Support and Policy Initiatives

    Supportive regulatory frameworks and policy initiatives are fostering growth in the Global Global Emphysema Market Industry. Governments worldwide are implementing policies aimed at reducing tobacco use and improving air quality, which are crucial in combating respiratory diseases. Initiatives such as smoking cessation programs and stricter emissions regulations are likely to contribute to a decrease in new emphysema cases. This regulatory environment not only encourages innovation in treatment but also promotes public health. As a result, the Global Global Emphysema Market Industry is positioned for growth, with expectations of reaching 13.5 USD Billion in 2024.

    Rising Prevalence of Respiratory Diseases

    The Global Global Emphysema Market Industry is experiencing growth due to the increasing prevalence of respiratory diseases. Factors such as air pollution, smoking, and occupational hazards contribute significantly to the rise in emphysema cases. According to health statistics, millions of individuals are diagnosed with chronic obstructive pulmonary disease (COPD), which includes emphysema, highlighting the urgent need for effective treatment options. This growing patient population is expected to drive market demand, with projections indicating that the market could reach 13.5 USD Billion in 2024. As awareness of respiratory health continues to rise, the Global Global Emphysema Market Industry is likely to expand further.

    Market Segment Insights

    Emphysema Type Insights

    On the basis of type, the market is segmented into centrilobular and panlobular emphysema.

    Emphysema Diagnosis Insights

    On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.

    Emphysema Treatment Insights

    On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.

    Emphysema End-User Insights

    On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.

    Get more detailed insights about Emphysema Market Research Report - Forecast to 2032

    Regional Insights

    Key Companies in the Emphysema Market market include

    Industry Developments

    Future Outlook

    Emphysema Market Future Outlook

    The Global Emphysema Market is projected to grow at a 4.83% CAGR from 2024 to 2035, driven by advancements in treatment options, increasing prevalence, and heightened awareness.

    New opportunities lie in:

    • Develop innovative drug delivery systems to enhance treatment efficacy.
    • Expand telehealth services for remote patient monitoring and management.
    • Invest in personalized medicine approaches to tailor therapies for individual patients.

    By 2035, the Global Emphysema Market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and increased patient engagement.

    Market Segmentation

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 12.23 (USD Billion)
    Market Size 2024 13.53 (USD Billion)
    Market Size 2032 19.83 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.64 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
      Key Market Opportunities Increasing population in urban areas across the globe and growing number of tobacco smokers.
      Key Market Drivers The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is Emphysema?

    Emphysema is a lung disease characterized by shortness of breath, causing damage to the air sacs in the lungs.

    What is the CAGR of the Emphysema Market?

    Global Emphysema Market is expected to exhibit a strong 4.64% CAGR over the forecast period from 2024 to 2032.

    What is the major driver for the Emphysema Market?

    The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Which is the major regional Emphysema Market?

    The Americas dominate the Global Emphysema Market.

    What are the key players in the Emphysema Market?

    Leading players in the Emphysema Market include Pulmonx Inc., Intrexon Corporation, and Halozyme Therapeutics, among others.

    1. Table of Content    
    2.     Report Prologue    
    3.     Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective    
        2.     Assumptions    
        3.     Limitations    
    4.     Research Methodology
      1.     Introduction
      2.     Primary Research    
      3.     Secondary research    
      4.     Market Size Estimation
    5.     Market Dynamics
      1.     Drivers    
      2.     Restrains
      3.     Opportunities    
      4.     Challenges
      5.     Macroeconomic Indicators
      6.     Technology Trends & Assessment            
    6.     Market Factor Analysis
      1.     Porters Five Forces Analysis
        1.     Bargaining Power of Suppliers    
        2.     Bargaining Power of Buyers
        3.     Threat of New Entrants    
        4.     Threat of Substitutes    
        5.     Intensity of Rivalry    
      2.     Value Chain Analysis
      3.     Investment Feasibility Analysis    
      4.     Pricing Analysis
    7.     Global Emphysema Market, by Type
    8.      6.1    Introduction
      1.     Centrilobular
        1.     Market Estimates & Forecast, 2023-2030
      2.     Panlobular
        1.     Market Estimates & Forecast, 2023-2030
    9.     Global Emphysema Market, by Diagnosis
    10.      7.1    Introduction
      1.     Imaging Test
        1.     Market Estimates & Forecast, 2023–2030
      2.     Lung Function Test
        1.     Market Estimates & Forecast, 2023–2030
      3.     Others
        1.     Market Estimates & Forecast, 2023–2030
    11.     Global Emphysema Market, by Treatment
    12.      8.1    Introduction
      1.     Medication 
        1.     Market Estimates & Forecast, 2023–2030
      2.     Therapy
        1.     Market Estimates & Forecast, 2023–2030
      3.     Surgery
        1.     Market Estimates & Forecast, 2023–2030
    13.     Global Emphysema Market, by End-User
      1.     Introduction
      2.     Hospitals & Clinics
        1.     Market Estimates & Forecast, 2023–2030
      3.     Surgical Center
        1.     Market Estimates & Forecast, 2023–2030
      4.     Others
        1.     Market Estimates & Forecast, 2023–2030
    14.     Global Emphysema Market, by Region
      1.     Introduction
      2.     Americas
        1.     North America
        2.     South America
      3.     Europe
        1.     Western Europe
        2.     Eastern Europe
      4.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.     Rest of Asia Pacific
      5.     The Middle East & Africa
        1.     United Arab Emirates
        2.      Saudi Arabia
        3.     Oman
        4.     Kuwait
        5.     Qatar
        6.     Rest of the Middle East & Africa
    15. 11    Company Landscape    
      1.     Introduction    
      2.     Market Share Analysis    
      3.     Key Development & Strategies    
        1.     Key Developments    
    16. 12    Company Profiles    
      1.     Intrexon Corporation
        1.     Company Overview    
        2.     Product Overview    
        3.     Financials    
        4.     SWOT Analysis    
      2.     Pulmonx Inc.
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.      Bioxyne Limited    
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      4.      PneumRx
        1.     Company Overview    
        2.     Product/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      5.     Uptake Medical Corporation
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments    
      6.     Icure Pharmaceuticals, Inc.
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
      7.     Pfizer, Inc.
        1.     Overview    
        2.     Product Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
    17.     12.8    Others
    18. 13    MRFR Conclusion    
      1.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
      2.     Key Companies to Watch    
      3.     Prediction of Diagnostic Tests Industry
    19. 14    Appendix
    20. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1        Emphysema Industry Synopsis, 2023-2030
      3. Table 2        Global Emphysema Market Estimates and Forecast, 2023-2030, (USD Million)
      4. Table 3        Global Emphysema Market by Region, 2023-2030, (USD Million)
      5. Table 4        Global Emphysema Market by Types, 2023-2030, (USD Million)
      6. Table 5        Global Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      7. Table 6        Global Emphysema Market by Treatment, 2023-2030, (USD Million)
      8. Table 7        Global Emphysema Market by End Users, 2023-2030, (USD Million)
      9. Table 8        North America Emphysema Market by Types, 2023-2030, (USD Million)
      10. Table 9        North America Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      11. Table 10    North America Emphysema Market by Treatment, 2023-2030, (USD Million)
      12. Table 11    North America Emphysema Market by End Users, 2023-2030, (USD Million)
      13. Table 12    US Emphysema Market by Types, 2023-2030, (USD Million)
      14. Table 13    US Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      15. Table 14    US Emphysema Market by Treatment, 2023-2030, (USD Million)
      16. Table 15    US Emphysema Market by End Users, 2023-2030, (USD Million)
      17. Table 16    Canada Emphysema Market by Types, 2023-2030, (USD Million)
      18. Table 17    Canada Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      19. Table 18    Canada Emphysema Market by Treatment, 2023-2030, (USD Million)
      20. Table 19    Canada Emphysema Market by End Users, 2023-2030, (USD Million)
      21. Table 20    South America Emphysema Market by Types, 2023-2030, (USD Million)
      22. Table 21    South America Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      23. Table 22    South America Emphysema Market by Treatment, 2023-2030, (USD Million)
      24. Table 23    South America Emphysema Market by End Users, 2023-2030, (USD Million)
      25. Table 24    Europe Emphysema Market by Types, 2023-2030, (USD Million)
      26. Table 25    Europe Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      27. Table 26    Europe Emphysema Market by Treatment, 2023-2030, (USD Million)
      28. Table 27    Europe Emphysema Market by End Users, 2023-2030, (USD Million)
      29. Table 28    Western Europe Emphysema Market by Types, 2023-2030, (USD Million)
      30. Table 29    Western Europe Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      31. Table 30    Western Europe Emphysema Market by Treatment, 2023-2030, (USD Million)
      32. Table 31    Western Europe Emphysema Market by End Users, 2023-2030, (USD Million)
      33. Table 32    Eastern Europe Emphysema Market by Types, 2023-2030, (USD Million)
      34. Table 33    Eastern Europe Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      35. Table 34    Eastern Europe Emphysema Market by Treatment, 2023-2030, (USD Million)
      36. Table 35    Eastern Europe Emphysema Market by End Users, 2023-2030, (USD Million)
      37. Table 36    Asia Pacific Emphysema Market by Types, 2023-2030, (USD Million)
      38. Table 37    Asia Pacific Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      39. Table 38    Asia Pacific Emphysema Market by Treatment, 2023-2030, (USD Million)
      40. Table 39    Asia Pacific Emphysema Market by End Users, 2023-2030, (USD Million)
      41. Table 40    Middle East & Africa Emphysema Market by Types, 2023-2030, (USD Million)
      42. Table 41    Middle East & Africa Emphysema Market by Diagnosis, 2023-2030, (USD Million)
      43. Table 42    Middle East & Africa Emphysema Market by Treatment, 2023-2030, (USD Million)
      44. Table 43    Middle East & Africa Emphysema Market by End Users, 2023-2030, (USD Million) LIST OF FIGURES
      45. Figure 1    Research Process
      46. Figure 2    Segmentation for Global Emphysema Market
      47. Figure 3    Segmentation Market Dynamics for Emphysema Market
      48. Figure 4    Global Emphysema Market Share, by Diagnosis 2023
      49. Figure 5    Global Emphysema Market Share, by Treatment 2023
      50. Figure 6    Global Emphysema Market Share, by End Users, 2023
      51. Figure 7    Global Emphysema Market Share, by Region, 2023
      52. Figure 8    North America Emphysema Market Share, by Country, 2023
      53. Figure 9    Europe Emphysema Market Share, by Country, 2023
      54. Figure 10    Asia Pacific Emphysema Market Share, by Country, 2023
      55. Figure 11    Middle East & Africa Emphysema Market Share, by Country, 2023
      56. Figure 12    Global Emphysema Market: Company Share Analysis, 2023 (%)
      57. Figure 13    Intrexon Corporation: Key Financials
      58. Figure 14    Intrexon Corporation: Segmental Revenue
      59. Figure 16    Intrexon Corporation: Geographical Revenue
      60. Figure 17    Pulmonx Inc.: Key Financials
      61. Figure 18    Pulmonx Inc.: Segmental Revenue
      62. Figure 19    Pulmonx Inc.: Geographical Revenue
      63. Figure 20    Uptake Medical Corporation: Key Financials
      64. Figure 21    Uptake Medical Corporation: Segmental Revenue
      65. Figure 22    Uptake Medical Corporation: Geographical Revenue
      66. Figure 23    PNEUMRX: Key Financials
      67. Figure 24    PNEUMRX: Segmental Revenue
      68. Figure 25    PNEUMRX: Geographical Revenue
      69. Figure 26    Olympus Corporation: Segmental Revenue
      70. Figure 27    Olympus Corporation: Geographical Revenue
      71. Figure 28    Olympus Corporation: Key Financials
      72. Figure 29    Icure Pharmaceuticals, Inc.: Segmental Revenue
      73. Figure 30    Icure Pharmaceuticals, Inc.: Geographical Revenue
      74. Figure 31    Icure Pharmaceuticals, Inc: Key Financials

    Emphysema Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027